# Study of Methemoglobin as a Biomarker of Tissue Hypoxia During Acute Hemodilution in Heart Surgery Patients

> **NCT01883713** · — · COMPLETED · sponsor: **Unity Health Toronto** · enrollment: 68 (actual)

## Conditions studied

- Other Functional Disturbances Following Cardiac Surgery

## Interventions

- **DEVICE:** Brain Oximetry

## Key facts

- **NCT ID:** NCT01883713
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01883713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01883713, "Study of Methemoglobin as a Biomarker of Tissue Hypoxia During Acute Hemodilution in Heart Surgery Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01883713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*